These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 18025202

  • 1. The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis.
    Hoffmann MH, Tuncel J, Skriner K, Tohidast-Akrad M, Türk B, Pinol-Roma S, Serre G, Schett G, Smolen JS, Holmdahl R, Steiner G.
    J Immunol; 2007 Dec 01; 179(11):7568-76. PubMed ID: 18025202
    [Abstract] [Full Text] [Related]

  • 2. Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice.
    Hayer S, Tohidast-Akrad M, Haralambous S, Jahn-Schmid B, Skriner K, Trembleau S, Dumortier H, Pinol-Roma S, Redlich K, Schett G, Muller S, Kollias G, Smolen J, Steiner G.
    J Immunol; 2005 Dec 15; 175(12):8327-36. PubMed ID: 16339574
    [Abstract] [Full Text] [Related]

  • 3. Immmunopathogenesis of rheumatoid arthritis; induction of arthritogenic autoimmune responses by proinflammatory stimuli.
    Hoffmann M, Hayer S, Steiner G.
    Ann N Y Acad Sci; 2009 Sep 15; 1173():391-400. PubMed ID: 19758178
    [Abstract] [Full Text] [Related]

  • 4. Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice.
    Steiner G, Shovman O, Skriner K, Gilburd B, Langevitz P, Miholits M, Hoet R, Levy Y, Zandman-Goddard G, Hoefler E, Smolen JS, Shoenfeld Y.
    Clin Exp Rheumatol; 2002 Sep 15; 20(4):517-24. PubMed ID: 12180437
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of Inflammation and Bone Erosion by RNA Interference-Mediated Silencing of Heterogeneous Nuclear RNP A2/B1 in Two Experimental Models of Rheumatoid Arthritis.
    Herman S, Fischer A, Presumey J, Hoffmann M, Koenders MI, Escriou V, Apparailly F, Steiner G.
    Arthritis Rheumatol; 2015 Sep 15; 67(9):2536-46. PubMed ID: 26017221
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus.
    Hassfeld W, Steiner G, Studnicka-Benke A, Skriner K, Graninger W, Fischer I, Smolen JS.
    Arthritis Rheum; 1995 Jun 15; 38(6):777-85. PubMed ID: 7779120
    [Abstract] [Full Text] [Related]

  • 11. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS.
    Arthritis Rheum; 1998 Nov 15; 41(11):1938-45. PubMed ID: 9811047
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
    Fritsch-Stork R, Müllegger D, Skriner K, Jahn-Schmid B, Smolen JS, Steiner G.
    Arthritis Res Ther; 2006 Nov 15; 8(4):R118. PubMed ID: 16859514
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-RA33 autoantibodies may recognize epitopes in the N-terminal region of hnRNP-A2 (RA33).
    Skriner K, Steiner G, Sommergruber WH, Sinski A, Smolen JS.
    Clin Exp Rheumatol; 1994 Nov 15; 12 Suppl 11():S79-82. PubMed ID: 7539351
    [Abstract] [Full Text] [Related]

  • 16. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS, Steiner G.
    J Clin Invest; 1997 Jul 01; 100(1):127-35. PubMed ID: 9202064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
    Patten C, Bush K, Rioja I, Morgan R, Wooley P, Trill J, Life P.
    Arthritis Rheum; 2004 Oct 01; 50(10):3334-45. PubMed ID: 15476226
    [Abstract] [Full Text] [Related]

  • 20. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.
    Siapka S, Patrinou-Georgoula M, Vlachoyiannopoulos PG, Guialis A.
    Autoimmunity; 2007 May 01; 40(3):223-33. PubMed ID: 17453722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.